XVIR THERAPEUTICS
Xvir Therapeutics GmbH was founded in 2004 and is focusing on the clinical development of novel cancer therapies for the treatment of various solid tumors, and in particular of drug-resistant or radiation-resistant tumors Such cancer therapies are based on the use of oncolytic adenoviruses restoring drug sensitivity and radiation-sensitivity, respectively, of the tumors. Experimental evidence for the efficacy of Xvir’s therapeutic approach has been provided in several animal studies. Xvir’s therapeutic approach is covered by proprietary patents and patent applications, respectively.
XVIR THERAPEUTICS
Industry:
Biotechnology Health Care Hospital
Founded:
2004-01-01
Address:
München, Bayern, Germany
Country:
Germany
Website Url:
http://www.xvir.com
Status:
Active
Contact:
+4908999317446
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt WordPress Apache Wordpress Plugins ReCAPTCHA ReCAPTCHA V2
Similar Organizations
AAPlasma
AAPlasma focus is engineering and development of cold plasma components for your industrial system.
Biomedical Catalyst Fund
Biomedical Catalyst Fund invests in the pre-clinical development and early clinical testing of novel therapeutics.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Official Site Inspections
http://www.xvir.com
- Host name: hp.wam24.com
- IP address: 195.28.12.36
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
